News
Bryan Johnson has launched a US$1m-a-year longevity programme with just three places, offering access to the exact protocol he has followed for five years. The programme, called "Immortals", is offered by the former fintech entrepreneur, now a prominent and often controversial figure in longevity. Johnson’s unconventional methods have included Botox injections in his genitals (Botox [...]
Re:Cognition Health and Cera have partnered to expand access to Alzheimer’s clinical trials across the UK. The collaboration links Re:Cognition Health’s specialist brain health clinics and trial expertise with Cera’s 2.5 million monthly home care visits, creating new pathways to identify and support people earlier in their health journey. By connecting home care with specialist [...]
Labcorp has launched what it describes as the first FDA-cleared blood test for Alzheimer's disease assessment in primary care settings nationwide. The Elecsys pTau-181 helps clinicians rule out the neurodegenerative disorder by identifying which symptomatic patients aged 55 and older are unlikely to have amyloid pathology, abnormal protein build-up in the brain associated with the [...]
Starlab Space has announced a partnership with Auxilium Biotechnologies to advance 3D bioprinting in orbit. Auxilium will provide orbital 3D bioprinting and biofabrication capabilities (manufacturing biological materials) aboard the Starlab space station to support research and development in regenerative medicine, implantable medical devices and tissue engineering. Regenerative medicine uses the body’s own materials to repair [...]
Dubai Healthcare City has expanded its longevity and pharmaceutical services at the World Health Expo Dubai 2026. The expansion brings together what the free zone describes as a new longevity-led preventive care programme and an AI-driven tele-compounding pharmacy platform. The additions expand the range of personalised care pathways available within the ecosystem, with a focus [...]
A French biotech has raised €12m to test whether GLP-1 drugs can modify osteoarthritis progression. The funding will advance 4Moving Biotech's lead programme, 4P004, toward a phase 2a proof-of-concept readout in knee osteoarthritis, a joint disease that causes pain and stiffness. Despite affecting more than 600 million people worldwide, no therapy approved in Europe or [...]
An EEG test can identify dementia risk five to seven years before progression to mild cognitive impairment or Alzheimer’s dementia, new research suggests. Using EEG data, which measures the brain’s electrical activity, from older adults with only subjective memory concerns, the longitudinal study found this non-invasive test can flag functional changes long before standard tools [...]
Harbor Health has acquired dementia care startup Rippl; terms were not disclosed. Founded in 2021, Rippl provides specialised dementia care and support, including personalised care plans, medication assessments and 24/7 access to care navigators and licensed clinicians. The Seattle-based company aims to help seniors with dementia stay at home and reduce emergency department visits. It [...]
The Scottish Medicines Consortium has declined to recommend the Alzheimer's therapy donanemab (Kisunla, Eli Lilly) for early-stage disease in NHS Scotland. The decision affects patients with mild cognitive impairment and mild dementia caused by Alzheimer's disease who are apolipoprotein E epsilon 4 heterozygotes or non-carriers, a genetic marker. The consortium cited uncertainty over clinical relevance [...]
People who drink two to three cups of coffee or tea daily have a lower dementia risk, new research suggests. Health records for more than 130,000 people showed that over 40 years, those who routinely drank two to three cups of caffeinated coffee or one to two cups of caffeinated tea daily had a 15 [...]
